Monogram Biosciences
Script error: No such module "Unsubst".Template:Short description Template:More footnotes Script error: No such module "Infobox".Template:Template otherScript error: No such module "Check for conflicting parameters".Script error: No such module "Check for unknown parameters".
Monogram Biosciences, Inc. (formerly ViroLogic Inc.) is an international biotechnology laboratory located in South San Francisco, California, USA and is a subsidiary of LabCorp. Monogram develops and markets assays to help guide and improve the treatment of infectious diseases (including HIV and Hepatitis) and cancer.
Virologic was founded in 1996 by Daniel Capon, Ph.D., Martin Goldstein and Robert S. Capon. The company went public (NASDAQ: VLGC) in 2000.[1]
Monogram was acquired by Laboratory Corporation of America in June 2009.[2]
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
External links
- Script error: No such module "Official website".Script error: No such module "Check for unknown parameters".
- Baseline HIV Type 1 Coreceptor Tropism Predicts Disease Progression [1]
- Four Studies Affirm Significance Of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay [2]
- Accuracy of Monogram's Trofile Assay in Determining Tropism and New Tropism Assays in Development [3]
- Trofile Bests SensiTrop as Most Reliable Tropism Test [4]
- Monogram Biosciences teams up with Pfizer for HIV treatment [5]
- Monogram Biosciences Launches New "Trofile" HIV Co-receptor Tropism Test to Select Patients Eligible to User CCR5 Antagonist Maraviroc (Selzentry) [6]
- Pages with script errors
- Biotechnology companies of the United States
- Biotechnology companies established in 1996
- Health care companies based in California
- Companies formerly listed on the Nasdaq
- Companies based in San Mateo County, California
- South San Francisco, California
- 2000 initial public offerings
- 2009 mergers and acquisitions